CD70-targeted immunoPET Imaging of Malignant Cancers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CD70-targeted immunoPET Imaging of Malignant Cancers — Stella

Recruiting

Back to Renal Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

Key details

Sponsor

RenJi Hospital

Enrollment target

~300 participants

Started

December 2024

Primary completion

December 2026

Age range

18 Years – 80 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov